顾自宽,讲师
2017年本科毕业于湖南大学化学专业,同年进入南京大学化学化工学院攻读博士学位,研究方向为基于仿生识别技术的纳米医学,并于2023年获得理学博士学位。迄今为止,发表SCI论文7篇,其中共同第一作者以及第一作者3篇,(Angew. Chem. Int. Ed; Chem. Sci; ASC Nano)二区及以下4篇。在就读博士期间,参与国家自然科学基金重点项目一项,国家自然科学基金青年项目一项。
教育/工作经历:
2023/12-至今 5060全讯白菜网,白菜网所有网站大全,讲师
2017.9-2023.6 南京大学, 化学化工学院分析化学专业,理学博士
2013.9-2017.6 湖南大学 化学化工学院化学专业,理学学士
研究方向:
基于仿生识别技术的纳米医学
发表论文:
[1]. Gu, Z. K+.; Dong, Y. R+.; Xu, S. X.; Wang, L. S.; Liu, Z., Molecularly Imprinted Polymer-Based Smart Prodrug Delivery System for Specific Targeting, Prolonged Retention, and Tumor Microenvironment-Triggered Release. Angew. Chem. Int. Ed. 2021, 60, 2663-2667.
[2]. Gu, Z. K+.; Xu, S. X+.; Guo, Z. C; Liu, Z., Rational development of molecularly imprinted nanoparticles for blocking PD-1/PD-L1 axis. Chem. Sci. 2022, 13, 10897-10903.
[3]. Gu, Z. K.; Guo, Z. C; Gao, S.; Huang, L. R.; Liu, Z., Hierarchically Structured Molecularly Imprinted Nanotransducers for Truncated HER2-Targeted Photodynamic Therapy of Therapeutic Antibody-Resistant Breast Cancer. ACS Nano 2023, 17, 10152-10163.
[4]. Dong, Y. R.; Li, W.; Gu, Z. K.; Xing, R. R.; Ma, Y. Y.; Zhang, Q.; Liu, Z., Inhibition of HER2-Positive Breast Cancer Growth by Blocking the HER2 Signaling Pathway with HER2-Glycan-Imprinted Nanoparticles. Angew. Chem. Int. Ed. 2019, 58, 10621-10625.
[5]. Xu, S. X; Zhao, M. H; Gu, Z. K.; Lu, H. F.; Liu, Z., Photothermal Therapy of Neuroblastoma via Polysialic Acid-Targeting Nanomissiles. Small 2022, 18, 2201671.
[6]. Lu, W. H.; Chen, J. R.; Guo, Z. C.; Ma, Y. Y.; Gu, Z. K; Liu, Z., Targeted degradation of ABCG2 for reversing multidrug resistance by hypervalent bispecific gold nanoparticle-anchored aptamer chimeras. Chem. Commun. 2023, 59, 3118-3121.
[7]. Xu, S. X.; Gu, Z. K; Lu, H. F.; Guan, P. X.; Liu, Z., Leveraging Macrophage-Mediated Cancer Immunotherapy via a Cascading Effect Induced by a Molecularly Imprinted Nanocoordinator. ACS Appl. Mater. Interfaces 2023, 15, 27658-27669.
[8]. Guan, P. X.; Guo, Z. C.; Xu, S. X.; Lu, H. F.; Wang, L. S.; Gu, Z. K; Liu, Z., Molecularly Imprinted Nanobeacons Redirect Innate Immune Killing towards Triple Negative Breast Cancer. Angew. Chem. Int. Ed. 2023, 62, e202301202.
E-mail: zikuangu@njtech.edu.cn